Ticker Details
Citius Pharmaceuticals, Inc. Citius Pharmaceuticals Inc is a specialty pharmaceutical company engaged in development and commercialization of therapeutic products for markets using patented or proprietary formulations and modified drug delivery technology.
IPO Date:	June 9, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$15.89M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.07 | 4.36%
Avg Daily Range (30 D):	$0.03 | 4.02%
Avg Daily Range (90 D):	$0.06 | 5.07%

Institutional Daily Volume
Avg Daily Volume:	.25M
Avg Daily Volume (30 D):	.42M
Avg Daily Volume (90 D):	.91M

Trade Size
Avg Trade Size (Sh.):	63
Avg Trade Size (Sh.) (30 D):	367
Avg Trade Size (Sh.) (90 D):	305

Institutional Trades
Total Institutional Trades:	45
Avg Institutional Trade:	$2.78M
Avg Institutional Trade (30 D):	$6.8M
Avg Institutional Trade (90 D):	$6.8M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$6.35M
Avg Closing Trade (30 D):	$6.8M
Avg Closing Trade (90 D):	$6.8M
Avg Closing Volume:	149.91K

News

Feb 13, 2026 @ 1:00 PM Citius Pharmaceuticals, Inc. Announces First Repor... Source: Prnewswire

Feb 13, 2026 @ 1:00 PM Citius Oncology, Inc. Announces First Reported Rev... Source: Prnewswire

Dec 24, 2025 @ 2:04 PM Stock Market Today: Dow Jones, Nasdaq Futures Slip... Source: Rishabh Mishra

Dec 10, 2025 @ 9:30 PM Citius Oncology Announces Closing of $18 Million C... Source: Prnewswire

Dec 9, 2025 @ 1:30 PM Citius Oncology Announces $18 Million Concurrent R... Source: Prnewswire

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.38	$-.11	$-3.38
Diluted EPS	$-.38	$-.11	$-3.38
Revenue	$3.94M	$M	$M
Gross Profit	$3.15M
Net Income / Loss	$-9.39M	$-8.74M	$-39.74M
Operating Income / Loss	$-9.02M	$-8.44M	$-38.53M
Cost of Revenue	$.79M
Net Cash Flow	$3.47M	$1M	$1M
PE Ratio

Splits
Nov 26, 2024	1:25
Jun 09, 2017	1:15
Sep 12, 2014	5:8